Chester County News and Community Website
KING OF PRUSSIA, PA — CSL (ASX: CSL) announced that the U.S. Food and Drug Administration (FDA) recently approved HEMGENIX® (etranacogene dezaparvovec-drlb), the first and only one-time gene therapy for appropriate …
U.S. Food and Drug Administration Approves CSL’s HEMGENIX (etranacogene dezaparvovec-drlb) Read More
The U.S. Food and Drug Administration recently approved Tzield (teplizumab-mzwv) injection to delay the onset of stage 3 type 1 diabetes in adults and pediatric patients 8 years and older …
FDA Approves First Drug That Can Delay Onset of Type 1 Diabetes Read More
WILMINGTON, DE — The Food and Drug Administration’s (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) recently voted 16 to 1 that the data support a favorable benefit-risk assessment for the use …
PT027 Recommended by FDA Advisory Committee as New Rescue Treatment for Asthma Read More
WILMINGTON, DE — Ashland Inc. (NYSE: ASH) announced the United States Food and Drug Administration (FDA) Center for Drug Evaluation and Research Office of New Drugs recently accepted Ashland Viatel™ …
Ashland Injectable Pharmaceutical Excipient Accepted into FDA Novel Excipient Review Pilot Program Read More
PHILADELPHIA, PA — Amicus Therapeutics (Nasdaq: FOLD) recently announced that the U.S. Food and Drug Administration (FDA) has deferred action on the Biologics License Application (BLA) for cipaglucosidase alfa, the …
FDA Defers Action on Filing for AT-GAA in Late-onset Pompe Disease Read More
The U.S. Department of Justice (DOJ), on behalf of the U.S. Food and Drug Administration, recently filed complaints for permanent injunctions in federal district courts against six e-cigarette manufacturers. These …
The FDA Filed Lawsuits Against 6 E-Cigarette Companies Read More
WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) announced that the U.S. Food and Drug Administration, (FDA) recently cleared the company to proceed with a Phase 1 study under its …
Prelude Therapeutics Receives FDA Clearance of IND for PRT3789 Read More
BERWYN, PA — Annovis Bio, Inc. (NYSE: ANVS) announced that the U.S. Food and Drug Administration (FDA) recently authorized the Phase 2/3 clinical study of buntanetap in moderate Alzheimer’s Disease …
Annovis Bio Announces FDA Authorization to Proceed with Phase 2/3 Trial for Buntanetap in Alzheimer’s Disease Read More
The U.S. Food and Drug Administration recenlty approved Boostrix (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed [Tdap]) for immunization during the third trimester of pregnancy to prevent …
Whooping cough vaccine: Boostrix approved for pregnant women Read More
The U.S. Food and Drug Administration, in coordination with the Centers for Disease Control and Prevention (CDC), released federal data from the 2022 National Youth Tobacco Survey (NYTS) on e-cigarette …
2.5 Million Middle and High School Students Are Using E-Cigarettes Read More